Quote Originally Posted by Delbert View Post
The MHRA (UK) has acted on partial data to speed up the approval process and the EMA (EU) has chosen to await analysis of all available data in order to instill the greatest degree of public confidence in a mass vaccination campaign. Whether you think the approach the UK has chosen is the right one is up to you.

We should of course be very grateful to the vaccine developers at the German company BioNTech whose work, part-funded by the EU and further developed in conjunction with the US company Pfizer, has brought us to where we are today.
Clearly you didn't see the press conference by the MHRA when they explained how they assessed the vaccine and worked with the pharmaceutical companies at each stage of the process which explained why they were able to reach their conclusion so swiftly.